11-20601262-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_004211.5(SLC6A5):​c.137C>G​(p.Pro46Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00608 in 1,583,946 control chromosomes in the GnomAD database, including 40 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0046 ( 3 hom., cov: 33)
Exomes 𝑓: 0.0062 ( 37 hom. )

Consequence

SLC6A5
NM_004211.5 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.635

Publications

2 publications found
Variant links:
Genes affected
SLC6A5 (HGNC:11051): (solute carrier family 6 member 5) This gene encodes a sodium- and chloride-dependent glycine neurotransmitter transporter. This integral membrane glycoprotein is responsible for the clearance of extracellular glycine during glycine-mediated neurotransmission. This protein is found in glycinergic axons and maintains a high presynaptic pool of neurotransmitter at glycinergic synapses. Mutations in this gene cause hyperekplexia; a heterogenous neurological disorder characterized by exaggerated startle responses and neonatal apnea. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2016]
SLC6A5 Gene-Disease associations (from GenCC):
  • hyperekplexia 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • hereditary hyperekplexia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006926596).
BP6
Variant 11-20601262-C-G is Benign according to our data. Variant chr11-20601262-C-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 303999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00462 (703/152308) while in subpopulation NFE AF = 0.00726 (494/68018). AF 95% confidence interval is 0.00673. There are 3 homozygotes in GnomAd4. There are 318 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC6A5NM_004211.5 linkc.137C>G p.Pro46Arg missense_variant Exon 2 of 16 ENST00000525748.6 NP_004202.4 Q9Y345-1Q4VAM4Q4VAM6
SLC6A5NM_001318369.2 linkc.-427C>G 5_prime_UTR_variant Exon 2 of 15 NP_001305298.1 Q9Y345-2Q4VAM4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC6A5ENST00000525748.6 linkc.137C>G p.Pro46Arg missense_variant Exon 2 of 16 1 NM_004211.5 ENSP00000434364.2 Q9Y345-1
SLC6A5ENST00000298923.11 linkn.137C>G non_coding_transcript_exon_variant Exon 2 of 15 1 ENSP00000298923.7 J3KNC4

Frequencies

GnomAD3 genomes
AF:
0.00463
AC:
705
AN:
152190
Hom.:
3
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00140
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00504
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00668
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00728
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.00427
AC:
834
AN:
195416
AF XY:
0.00438
show subpopulations
Gnomad AFR exome
AF:
0.00120
Gnomad AMR exome
AF:
0.00219
Gnomad ASJ exome
AF:
0.000112
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00634
Gnomad NFE exome
AF:
0.00760
Gnomad OTH exome
AF:
0.00534
GnomAD4 exome
AF:
0.00623
AC:
8924
AN:
1431638
Hom.:
37
Cov.:
31
AF XY:
0.00595
AC XY:
4231
AN XY:
710788
show subpopulations
African (AFR)
AF:
0.00124
AC:
41
AN:
33180
American (AMR)
AF:
0.00226
AC:
96
AN:
42570
Ashkenazi Jewish (ASJ)
AF:
0.0000778
AC:
2
AN:
25692
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38952
South Asian (SAS)
AF:
0.000369
AC:
31
AN:
84098
European-Finnish (FIN)
AF:
0.00769
AC:
293
AN:
38108
Middle Eastern (MID)
AF:
0.00155
AC:
8
AN:
5162
European-Non Finnish (NFE)
AF:
0.00739
AC:
8158
AN:
1104420
Other (OTH)
AF:
0.00496
AC:
295
AN:
59456
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
588
1177
1765
2354
2942
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
306
612
918
1224
1530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00462
AC:
703
AN:
152308
Hom.:
3
Cov.:
33
AF XY:
0.00427
AC XY:
318
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.00140
AC:
58
AN:
41574
American (AMR)
AF:
0.00503
AC:
77
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5166
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00668
AC:
71
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00726
AC:
494
AN:
68018
Other (OTH)
AF:
0.000947
AC:
2
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
37
74
111
148
185
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00283
Hom.:
1
Bravo
AF:
0.00433
ExAC
AF:
0.00405
AC:
455
Asia WGS
AF:
0.000578
AC:
2
AN:
3474

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Sep 12, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SLC6A5: BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Hyperekplexia 3 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hyperekplexia Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.084
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.46
CADD
Benign
14
DANN
Benign
0.92
DEOGEN2
Benign
0.025
T
Eigen
Benign
-0.66
Eigen_PC
Benign
-0.54
FATHMM_MKL
Benign
0.49
N
LIST_S2
Benign
0.59
T
MetaRNN
Benign
0.0069
T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
0.0
N
PhyloP100
0.64
PrimateAI
Uncertain
0.61
T
PROVEAN
Benign
-0.19
N
REVEL
Benign
0.063
Sift
Benign
0.24
T
Sift4G
Benign
0.35
T
Polyphen
0.026
B
Vest4
0.30
MVP
0.71
MPC
0.21
ClinPred
0.010
T
GERP RS
3.0
Varity_R
0.036
gMVP
0.16
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12364685; hg19: chr11-20622808; API